Assessing disease activity in Crohn's disease - Are we there yet?

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 10, 1997, Pages 929-930

  Eliakim, Rami ^a   Rachmilewitz, Daniel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Acid 1 glycoprotein; Crohn's disease; Interleukin 6; Recombinant interleukin 2; Tumour necrosis factor

Indexed keywords

ALPHA1 GLYCOPROTEIN; CYTOKINE; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

CROHN DISEASE; DISEASE ACTIVITY; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHORT SURVEY;

EID: 0030874686     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199710000-00001     Document Type: Short Survey

References (7)

1. Bartholomeuez FDL, Sherman DJC: Measurement of activity in Crohn's disease. J Gastroenterol Hepatol 1989, 4:81-94.
2. Harvey RF, Bradshaw JM: A simple index of Crohn's disease activity. Lancet 1980, i:514.
3. Ogorek CP, Caroline DF, Fisher RS: Presentation, evaluation and natural history of inflammatory bowel disease. In Inflammatory Bowel Disease. Edited by MacDermott RP, Stenson WF. Amsterdam: Elsevier Science Publishers; 1992:355-386.
4. Sartor RB: Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995; 24:475-507.
5. Fiocchi C: Cytokines. In Inflammatory Bowel Disease. Edited by MacDermott RP, Stenson WF. Amsterdam: Elsevier Science Publishers; 1992:137-162.
6. Sun X-M, Hsueh W: Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet activating factor. J Clin Invest 1988, 84:1328-1331.
7. Mueller C, Knoflach P, Zielinski CC: T cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990, 98:639-646.